DaVita (NYSE:DVA) Sets New 52-Week High at $152.35

DaVita Inc. (NYSE:DVA)’s stock price hit a new 52-week high during trading on Thursday . The company traded as high as $152.35 and last traded at $152.26, with a volume of 246670 shares changing hands. The stock had previously closed at $150.60.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on DVA. UBS Group raised their price target on DaVita from $169.00 to $175.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. Bank of America lifted their price target on shares of DaVita from $139.00 to $145.00 and gave the stock an “underperform” rating in a research note on Wednesday, August 7th. TD Cowen increased their price objective on shares of DaVita from $139.00 to $150.00 and gave the stock a “hold” rating in a research report on Wednesday, July 24th. Truist Financial boosted their target price on DaVita from $150.00 to $165.00 and gave the company a “hold” rating in a research report on Tuesday. Finally, StockNews.com downgraded DaVita from a “strong-buy” rating to a “buy” rating in a report on Saturday, June 8th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, DaVita has an average rating of “Hold” and an average target price of $157.00.

DaVita Stock Performance

The company has a debt-to-equity ratio of 9.94, a current ratio of 1.16 and a quick ratio of 1.12. The company has a market cap of $13.36 billion, a PE ratio of 17.30, a price-to-earnings-growth ratio of 0.87 and a beta of 0.87. The business has a fifty day simple moving average of $140.84 and a two-hundred day simple moving average of $135.78.

DaVita (NYSE:DVA) last released its quarterly earnings results on Tuesday, August 6th. The company reported $2.59 EPS for the quarter, beating the consensus estimate of $2.47 by $0.12. The business had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.15 billion. DaVita had a net margin of 6.86% and a return on equity of 77.00%. The company’s quarterly revenue was up 6.2% on a year-over-year basis. During the same period in the prior year, the firm posted $2.08 earnings per share. Research analysts anticipate that DaVita Inc. will post 9.9 earnings per share for the current year.

Insider Activity at DaVita

In other news, COO Michael David Staffieri sold 9,539 shares of DaVita stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $150.03, for a total transaction of $1,431,136.17. Following the completion of the sale, the chief operating officer now directly owns 241,945 shares in the company, valued at $36,299,008.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other DaVita news, insider Kathleen Alyce Waters sold 7,857 shares of the firm’s stock in a transaction that occurred on Tuesday, August 13th. The shares were sold at an average price of $146.21, for a total transaction of $1,148,771.97. Following the completion of the transaction, the insider now directly owns 83,011 shares of the company’s stock, valued at approximately $12,137,038.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, COO Michael David Staffieri sold 9,539 shares of the company’s stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $150.03, for a total transaction of $1,431,136.17. Following the completion of the sale, the chief operating officer now directly owns 241,945 shares in the company, valued at $36,299,008.35. The disclosure for this sale can be found here. 2.00% of the stock is currently owned by insiders.

Institutional Trading of DaVita

Hedge funds have recently modified their holdings of the stock. SG Americas Securities LLC grew its position in DaVita by 196.9% during the first quarter. SG Americas Securities LLC now owns 29,733 shares of the company’s stock valued at $4,105,000 after buying an additional 19,719 shares during the period. Truist Financial Corp grew its position in shares of DaVita by 54.4% during the 4th quarter. Truist Financial Corp now owns 26,068 shares of the company’s stock valued at $2,731,000 after acquiring an additional 9,180 shares during the period. Bessemer Group Inc. increased its stake in shares of DaVita by 2,335.6% in the 1st quarter. Bessemer Group Inc. now owns 10,741 shares of the company’s stock valued at $1,483,000 after purchasing an additional 10,300 shares in the last quarter. Forsta AP Fonden raised its holdings in DaVita by 50.3% in the 1st quarter. Forsta AP Fonden now owns 23,600 shares of the company’s stock worth $3,258,000 after purchasing an additional 7,900 shares during the period. Finally, Fox Hill Wealth Management boosted its position in DaVita by 138.4% during the first quarter. Fox Hill Wealth Management now owns 15,734 shares of the company’s stock worth $2,172,000 after purchasing an additional 9,135 shares in the last quarter. Hedge funds and other institutional investors own 90.12% of the company’s stock.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.